Free Trial

Vir Biotechnology (VIR) SEC Filings & 10K Form

Vir Biotechnology logo
$6.16 +0.08 (+1.32%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$6.34 +0.18 (+2.84%)
As of 05/2/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
04/28/2025
12:02 PM
BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
Form SCHEDULE 13G/A
04/17/2025
8:27 AM
Vir Biotechnology (Filer)
Form ARS
04/17/2025
7:40 AM
Vir Biotechnology (Filer)
Form DEFA14A
04/17/2025
7:33 AM
Vir Biotechnology (Filer)
Form DEF 14A
04/04/2025
3:23 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:50 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
11:39 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:01 AM
Vir Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:23 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
2:43 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:44 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:34 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:36 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:37 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:39 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:41 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
7:56 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:38 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:40 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
6:11 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:50 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:41 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:49 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:51 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:03 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:22 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
6:50 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
12:36 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:20 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:51 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:20 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:26 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
11:29 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
10/02/2024
11:09 AM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
11:07 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:28 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:10 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:43 PM
Vir Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Gold Alert: The Truth About Fort Knox Is Coming (Ad)

Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.

Click here now before the biggest gold run in decades kicks off.
07/16/2024
3:40 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
2:26 PM
SHARP PHILLIP A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
7:15 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
11:21 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:01 PM
PEREZ ROBERT J (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
5:04 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
11:15 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:16 AM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:17 AM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:18 AM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
10:57 AM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2024
10:59 AM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:08 AM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:13 AM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:14 AM
NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:38 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:40 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:42 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:43 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM
Vir Biotechnology (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIR) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners